Paraneoplastic syndrome: Difference between revisions

Jump to navigation Jump to search
Sahar Memar Montazerin (talk | contribs)
No edit summary
Sahar Memar Montazerin (talk | contribs)
No edit summary
Line 15: Line 15:
| align="center" style="background:#4479BA; color: #FFFFFF;" |'''Associated Cancers'''
| align="center" style="background:#4479BA; color: #FFFFFF;" |'''Associated Cancers'''
|-
|-
| rowspan="5"  align="center" style="background:#f0f0f0;" |[[Endocrine|Endocrine metabolic]] <ref>{{MeshName|Paraneoplastic+endocrine+syndromes}}</ref><ref name="pmid15673803">{{cite journal |vauthors=Stewart AF |title=Clinical practice. Hypercalcemia associated with cancer |journal=N. Engl. J. Med. |volume=352 |issue=4 |pages=373–9 |date=January 2005 |pmid=15673803 |doi=10.1056/NEJMcp042806 |url=}}</ref><ref name="pmid16337807">{{cite journal |vauthors=Spinazzé S, Schrijvers D |title=Metabolic emergencies |journal=Crit. Rev. Oncol. Hematol. |volume=58 |issue=1 |pages=79–89 |date=April 2006 |pmid=16337807 |doi=10.1016/j.critrevonc.2005.04.004 |url=}}</ref>
| rowspan="5"  align="center" style="background:#f0f0f0;" |[[Endocrine|Endocrine metabolic]]  
|[[Hypercalcemia]]
|
* [[Hypercalcemia]]
|[[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])[[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
|[[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])[[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
*  
*  
|-
|-
|
|
* [[Syndrome of inappropriate antidiuretic hormone|SIADH]]<ref name="pmid17701059">{{cite journal |vauthors=Raftopoulos H |title=Diagnosis and management of hyponatremia in cancer patients |journal=Support Care Cancer |volume=15 |issue=12 |pages=1341–7 |date=December 2007 |pmid=17701059 |doi=10.1007/s00520-007-0309-9 |url=}}</ref><ref name="pmid17507705">{{cite journal |vauthors=Ellison DH, Berl T |title=Clinical practice. The syndrome of inappropriate antidiuresis |journal=N. Engl. J. Med. |volume=356 |issue=20 |pages=2064–72 |date=May 2007 |pmid=17507705 |doi=10.1056/NEJMcp066837 |url=}}</ref>||[[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
* [[Syndrome of inappropriate antidiuretic hormone|SIADH]]||[[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
*  
*  
|-
|-
Line 33: Line 34:
|-
|-
|
|
* [[Hypoglycemia]]<ref name="pmid9876347">{{cite journal |vauthors=Teale JD, Marks V |title=Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH) |journal=Clin. Endocrinol. (Oxf) |volume=49 |issue=4 |pages=491–8 |date=October 1998 |pmid=9876347 |doi= |url=}}</ref>
* [[Hypoglycemia]]
|[[Gastrointestinal tract|GI]] cancers, [[mesothelioma]], [[lung]], and [[sarcomas]]
|[[Gastrointestinal tract|GI]] cancers, [[mesothelioma]], [[lung]], and [[sarcomas]]
|-
|-
| rowspan="6"  align="center" style="background:#f0f0f0;" |[[Mucocutaneous|Musculocutaneous]]<ref name="pmid9208889">{{cite journal |author=Cohen PR, Kurzrock R |title=Mucocutaneous paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=334–59 |year=1997 |pmid=9208889 |doi=}}</ref>
| rowspan="6"  align="center" style="background:#f0f0f0;" |[[Mucocutaneous|Musculocutaneous]]
|
|
* [[Dermatomyositis]]  
* [[Dermatomyositis]]  
Line 69: Line 70:
|+
|+
|-
|-
| rowspan="11"  align="center" style="background:#f0f0f0;" |[[Neurological]]<ref>{{MeshName|Nervous+system+paraneoplastic+syndromes}}</ref><ref name="pmid19620862">{{cite journal |vauthors=Didelot A, Honnorat J |title=Update on paraneoplastic neurological syndromes |journal=Curr Opin Oncol |volume=21 |issue=6 |pages=566–72 |date=November 2009 |pmid=19620862 |doi=10.1097/CCO.0b013e3283306647 |url=}}</ref>
| rowspan="11"  align="center" style="background:#f0f0f0;" |[[Neurological]]
|
|
* [[Paraneoplastic cerebellar degeneration]]
* [[Paraneoplastic cerebellar degeneration]]
Line 94: Line 95:
*  
*  
|-
|-
|[[Encephalitis]]<ref name="pmid17262855">{{cite journal |author=Dalmau J, Tüzün E, Wu HY, ''et al'' |title=Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma |journal=Ann. Neurol. |volume=61 |issue=1 |pages=25–36 |year=2007 |month=January |pmid=17262855 |pmc=2430743 |doi=10.1002/ana.21050 |url=}}</ref>||[[teratoma]]
|
* [[Encephalitis]]
|[[teratoma]]
|-
|-
|
|
Line 117: Line 120:
|
|
|-
|-
| rowspan="4"  align="center" style="background:#f0f0f0;" |[[Hematological]]<ref name="pmid9208888">{{cite journal |author=Staszewski H |title=Hematological paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=329–33 |year=1997 |pmid=9208888 |doi=}}</ref><ref name="pmid8400277">{{cite journal |vauthors=Blay JY, Favrot M, Rossi JF, Wijdenes J |title=Role of interleukin-6 in paraneoplastic thrombocytosis |journal=Blood |volume=82 |issue=7 |pages=2261–2 |date=October 1993 |pmid=8400277 |doi= |url=}}</ref>
| rowspan="4"  align="center" style="background:#f0f0f0;" |[[Hematological]]
|
|
* [[Granulocytosis]]  
* [[Granulocytosis]]  
Line 142: Line 145:
==Causes==
==Causes==
===Common Causes===
===Common Causes===
* The major [[causes]] of paraneoplastic syndrome include:<ref name="pmid1591305">{{cite journal| author=Richardson GE, Johnson BE| title=Paraneoplastic syndromes in lung cancer. | journal=Curr Opin Oncol | year= 1992 | volume= 4 | issue= 2 | pages= 323-33 | pmid=1591305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1591305  }}</ref><ref name="pmid8946620">{{cite journal| author=Gold PJ, Fefer A, Thompson JA| title=Paraneoplastic manifestations of renal cell carcinoma. | journal=Semin Urol Oncol | year= 1996 | volume= 14 | issue= 4 | pages= 216-22 | pmid=8946620 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8946620  }}</ref><ref name="pmid191296132">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref>
* The major [[causes]] of paraneoplastic syndrome include:
**[[Small cell lung cancer]]
**[[Small cell lung cancer]]
** [[Non-small cell lung cancer]]
** [[Non-small cell lung cancer]]
Line 159: Line 162:
** [[Renal carcinoma]]
** [[Renal carcinoma]]
===Causes by Organ System===
===Causes by Organ System===
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system.<ref name="pmid20810794">{{cite journal| author=Pelosof LC, Gerber DE| title=Paraneoplastic syndromes: an approach to diagnosis and treatment. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 9 | pages= 838-54 | pmid=20810794 | doi=10.4065/mcp.2010.0099 | pmc=2931619 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20810794  }} </ref><ref name="pmid30876820">{{cite journal |vauthors=Henry K |title=Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment |journal=Semin Diagn Pathol |volume=36 |issue=4 |pages=204–210 |date=July 2019 |pmid=30876820 |doi=10.1053/j.semdp.2019.01.002 |url=}}</ref>
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system.
{| style="width:82%; height:100px" border="1"
{| style="width:82%; height:100px" border="1"
|-
|-
Line 342: Line 345:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]<ref name="NCCN">[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014]</ref><ref name="CarterGlisson2014">{{cite journal|last1=Carter|first1=Brett W.|last2=Glisson|first2=Bonnie S.|last3=Truong|first3=Mylene T.|last4=Erasmus|first4=Jeremy J.|title=Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations|journal=RadioGraphics|volume=34|issue=6|year=2014|pages=1707–1721|issn=0271-5333|doi=10.1148/rg.346140178}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Cough]]
* [[Cough]]
Line 377: Line 380:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]<ref name="Rosado-de-ChristensonTempleton1994">{{cite journal|last1=Rosado-de-Christenson|first1=M L|last2=Templeton|first2=P A|last3=Moran|first3=C A|title=Bronchogenic carcinoma: radiologic-pathologic correlation.|journal=RadioGraphics|volume=14|issue=2|year=1994|pages=429–446|issn=0271-5333|doi=10.1148/radiographics.14.2.8190965}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]]  at first
* [[Asymptomatic]]  at first
Line 415: Line 418:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]<ref name="ReynoldsFurlan2015">{{cite journal|last1=Reynolds|first1=Arich R.|last2=Furlan|first2=Alessandro|last3=Fetzer|first3=David T.|last4=Sasatomi|first4=Eizaburo|last5=Borhani|first5=Amir A.|last6=Heller|first6=Matthew T.|last7=Tublin|first7=Mitchell E.|title=Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know|journal=RadioGraphics|volume=35|issue=2|year=2015|pages=371–386|issn=0271-5333|doi=10.1148/rg.352140114}}</ref><ref name="FloresLang2011">{{cite journal|last1=Flores|first1=Yvonne N.|last2=Lang|first2=Cathy M.|last3=Salmerón|first3=Jorge|last4=Bastani|first4=Roshan|title=Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico|journal=Journal of Community Health|volume=37|issue=2|year=2011|pages=403–411|issn=0094-5145|doi=10.1007/s10900-011-9457-4}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first
Line 469: Line 472:
!Additional findings
!Additional findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]<ref name="Mišković2016">{{cite journal|last1=Mišković|first1=Josip|title=DIAGNOSTIC VALUE OF FINE NEEDLE ASPIRATION CYTOLOGY FOR BREAST TUMORS|journal=ACTA CLINICA CROATICA|year=2016|pages=625–628|issn=03539466|doi=10.20471/acc.2016.55.04.13}}</ref><ref name="pmid29117654">{{cite journal| author=Mišković J, Zorić A, Radić Mišković H, Šoljić V| title=Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors | journal=Acta Clin Croat | year= 2016 | volume= 55 | issue= 4 | pages= 625-628 | pmid=29117654 | doi=10.20471/acc.2016.55.04.13 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29117654  }}</ref><ref name="pmid8004594">{{cite journal| author=McKenna RJ| title=The abnormal mammogram radiographic findings, diagnostic options, pathology, and stage of cancer diagnosis. | journal=Cancer | year= 1994 | volume= 74 | issue= 1 Suppl | pages= 244-55 | pmid=8004594 | doi=10.1002/cncr.2820741308 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8004594  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Lump]] in the [[breast]]
* [[Lump]] in the [[breast]]
Line 502: Line 505:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]<ref name="CairnsSrivastava2011">{{cite journal|last1=Cairns|first1=Paul|last2=Srivastava|first2=Sudhir|last3=Grizzle|first3=William E.|title=Renal cell carcinoma|journal=Cancer Biomarkers|volume=9|issue=1-6|year=2011|pages=461–473|issn=18758592|doi=10.3233/CBM-2011-0176}}</ref><ref name="pmid7769125">{{cite journal| author=de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR et al.| title=Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. | journal=J Clin Invest | year= 1995 | volume= 95 | issue= 6 | pages= 2846-52 | pmid=7769125 | doi=10.1172/JCI117990 | pmc=295971 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7769125  }}</ref><ref name="pmid3306861">{{cite journal| author=Laski ME, Vugrin D| title=Paraneoplastic syndromes in hypernephroma. | journal=Semin Nephrol | year= 1987 | volume= 7 | issue= 2 | pages= 123-30 | pmid=3306861 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3306861  }}</ref><ref name="pmid20479778">{{cite journal| author=Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N| title=Imaging renal cell carcinoma with ultrasonography, CT and MRI. | journal=Nat Rev Urol | year= 2010 | volume= 7 | issue= 6 | pages= 311-25 | pmid=20479778 | doi=10.1038/nrurol.2010.63 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479778  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Hematuria]]
* [[Hematuria]]
Line 544: Line 547:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]<ref name="pmid19129613">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref><ref name="pmid15960930">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930  }}</ref><ref name="HollyChaliha2004">{{cite journal|last1=Holly|first1=Elizabeth A.|last2=Chaliha|first2=Indranushi|last3=Bracci|first3=Paige M.|last4=Gautam|first4=Manjushree|title=Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area|journal=Clinical Gastroenterology and Hepatology|volume=2|issue=6|year=2004|pages=510–517|issn=15423565|doi=10.1016/S1542-3565(04)00171-5}}</ref><ref name="pmid26495795">{{cite journal| author=Schmidt-Hansen M, Berendse S, Hamilton W| title=Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. | journal=Pancreas | year= 2016 | volume= 45 | issue= 6 | pages= 814-8 | pmid=26495795 | doi=10.1097/MPA.0000000000000527 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26495795  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Epigastric]] [[pain]]
* [[Epigastric]] [[pain]]
Line 588: Line 591:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]<ref name="pmid23667204">{{cite journal| author=Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C et al.| title=Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 5 | pages= 531-46 | pmid=23667204 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23667204  }}</ref><ref name="pmid8239772">{{cite journal| author=Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R| title=Cancer of the stomach. A patient care study by the American College of Surgeons. | journal=Ann Surg | year= 1993 | volume= 218 | issue= 5 | pages= 583-92 | pmid=8239772 | doi=10.1097/00000658-199321850-00002 | pmc=1243028 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8239772  }}</ref><ref name="pmid3357941">{{cite journal| author=Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM et al.| title=Gastric adenocarcinoma: CT versus surgical staging. | journal=Radiology | year= 1988 | volume= 167 | issue= 2 | pages= 335-40 | pmid=3357941 | doi=10.1148/radiology.167.2.3357941 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3357941  }}</ref><ref name="pmid7859977">{{cite journal| author=Karita M, Tada M| title=Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. | journal=Gastrointest Endosc | year= 1994 | volume= 40 | issue= 6 | pages= 749-53 | pmid=7859977 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7859977  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of [[gastric ulcer]]  
* History of [[gastric ulcer]]  
Line 634: Line 637:
* [[Acanthosis nigricans]]
* [[Acanthosis nigricans]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]]<ref name="pmid15245605">{{cite journal| author=Hagler KT, Lynch JW| title=Paraneoplastic manifestations of lymphoma. | journal=Clin Lymphoma | year= 2004 | volume= 5 | issue= 1 | pages= 29-36 | pmid=15245605 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15245605  }}</ref><ref name="pmid21339498">{{cite journal| author=Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC et al.| title=Spectrum of paraneoplastic disease associated with lymphoma. | journal=Neurology | year= 2011 | volume= 76 | issue= 8 | pages= 705-10 | pmid=21339498 | doi=10.1212/WNL.0b013e31820d62eb | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21339498  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Weight loss]]
* [[Weight loss]]
Line 663: Line 666:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]<ref name="pmid22217630">{{cite journal| author=Hippisley-Cox J, Coupland C| title=Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. | journal=BMJ | year= 2011 | volume= 344 | issue=  | pages= d8009 | pmid=22217630 | doi=10.1136/bmj.d8009 | pmc=3251328 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22217630  }}</ref><ref name="pmid22405464">{{cite journal| author=Li J, Fadare O, Xiang L, Kong B, Zheng W| title=Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. | journal=J Hematol Oncol | year= 2012 | volume= 5 | issue=  | pages= 8 | pmid=22405464 | doi=10.1186/1756-8722-5-8 | pmc=3328281 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22405464  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first

Revision as of 19:57, 11 October 2019

PCFor patient information, click here

Paraneoplastic syndrome Microchapters

Patient Information

Overview

Classification

Endocrine
Musculocutaneous
Neurological
Hematological
Others

Causes

Differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2] Synonyms and keywords: Paraneoplastic syndrome

Overview

Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.

Classification

  • Paraneoplastic syndromes may be classified into 5 main categories accordingly:
Type of paraneoplastic syndrome Subtype Associated Cancers
Endocrine metabolic breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)multiple myeloma, renal cell carcinoma, ovarian cancer, endometrial cancer, and lymphoma
GI cancers, mesothelioma, lung, and sarcomas
Musculocutaneous
gastrointestinal adenocarcinomas (gastric, colon, rectal), breast cancer, and lymphoproliferative disorders/lymphoma, and melanoma.
gastric adenocarcinoma, endometrial cancer, and etc.
Neurological
teratoma
Hematological
Others

Causes

Common Causes

Causes by Organ System

  • Paraneoplastic syndromes causes may be regrouped by organ system.
Dermatologic
Ear Nose Throat
Endocrine
Gastroenterologic
Hematologic
Musculoskeletal/Orthopedic
Neurologic
Obstetric/Gynecologic
Oncologic
Pulmonary
Renal/Electrolyte
Rheumatology/Immunology/Allergy
  • No underlying causes
Urologic
Miscellaneous

Differential diagnosis

Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Small cell lung cancer _ _ Small, round and oval cells

Necrosis

Biopsy _
Squamous lung cancer


_ _ _ _
Hepatocellular carcinoma _ _ _ _
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Breast cancer _ _ _ _ _ _
Renal cancer _ _
  • Depends on the subtypes
_
Pancreatic cancer _
  • U/S: hypoechoic mass
_
Gastric cancer


_ _ _
Lymphoma] _ _ _ _
  • Depends on the type of lymphoma
_
Ovarian cancer _ _

References